Egypt's Sisi ratifies extension of state of emergency for three months    Turkey hopes Mediterranean talks can calm choppy waters with EU    New daily Coronavirus cases continued to fall over the weekend    Egypt will inoculate medical staff with COVID-19 vaccination this week    Manchester City's Guardiola says Foden must not look to emulate De Bruyne    South African mourns death of jazz 'giant' Jonas Gwangwa    Klopp says Burnley shock can spark Liverpool turnaround    Eight cabinet ministers to deliver statements before Egypt's parliament this week    3,000 arrested at protests demanding Navalny's release    China rescues nine miners after 14 days trapped underground: CCTV    Italy to rethink COVID-19 vaccine roll out if supply problems persist    Sudan celebrates World Day for African and Afro-descendant Culture    BREAKING: Larry King, broadcasting giant for half-century, dies at 87    Africa is the world's next business frontier, says AfDB's President    Sudan reiterates concerns over planned 2nd GERD filling without binding deal    Britain to discuss tighter travel restrictions: BBC    Egypt's Sisi will inaugurate fish farming project in Port Said Saturday    Egypt, China agree to complete work at business district in New Capital    Swimming Australia eyes Plan B in case of Tokyo cancellation    IMF urges deficit control in Tunisia even as protesters demand jobs    Egypt reports 748 new coronavirus cases, 52 deaths on Friday    Egypt, China sign agreement to complete work at business district in New Administrative Capital    In Photos: Egypt's Sisi tours Police Academy on Friday    Donald Trump says goodbye to the White House    BREAKING: Egypt resumes diplomatic relations with Qatar ending 4-year boycott    Egypt reports 899 new coronavirus cases, 58 deaths on Tuesday    Egypt sends medical supplies to help Jordan battle coronavirus    Egypt eyes gradual return for tourism after revenues fall to $4 bln in 2020    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    Coronavirus strikes Egypt's youth team as 17 players, coach test positive    Nassef Sawiris plans to up his stake in owner of New York Knicks, Rangers    Cairo International Book Fair suspended for five months over coronavirus concerns    Egypt unveils largest archaeological discovery in 2020 with over 100 intact sarcophagi    Trump says won't blame Egypt for being ‘upset' over GERD dispute with Ethiopia    Egypt, Ethiopia, Sudan to resume Nile dam talks today    Global Finance: Egypt's Tarek Amer among the world's top 20 central bank governors    The Facebook Preacher's Search for Fame, and Egypt's Economy    Egypt calls on UNSC to address oil spill risks off Yemen coast    Egypt economically strong in face of COVID-19, reforms ongoing: International Cooperation Minister    Arafa Holding reports $144,000 COVID-19-related losses in April    Egypt's efforts in Libya to activate free will of Libyan people: Al-Sisi    Hyksos campaigns were internal takeover, not foreign invaders: study    COVID-19 affects Egypt sporting clubs    COVID-19 will soon turn to seasonal like swine flu: Presidential Health Advisor    ‘Egypt's Support' coalition convenes to discuss its Senate election list    Robbery attempt leads to discovery of Ptolemaic monuments in Qena    Flouting international guidance, Ethiopia unilaterally starts filling its Nile dam    Zaha speaks out after online racial abuse    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





AstraZeneca novel COVID-19 vaccine can be 90% effective, results show
Published in Amwal Al Ghad on 23 - 11 - 2020

AstraZeneca announced that its vaccine for the novel coronavirus could be around 90 percent effective without any serious side effects, the latest drugmaker to unveil positive interim data in a scientific race to curb a global pandemic.
The vaccine developed by Oxford University was 90% effective in preventing COVID-19 when it was administered as a half dose followed by a full dose at least one month apart, according to data from the late-stage trials in Britain and Brazil.
No serious safety events related to the vaccine have been confirmed and it was well tolerated across both dosing regimens, it said.


Clic here to read the story from its source.